NCT00125203View on ClinicalTrials.gov

Study of Myobloc in the Treatment of Sialorrhea (Drooling) in Patients With Amyotrophic Lateral Sclerosis (ALS)

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

July 31, 2003

Study Completion Date

August 31, 2007

Conditions
Amyotrophic Lateral SclerosisSialorrhea
Interventions
DRUG

Botulinum toxin type B (Myobloc)

PROCEDURE

Injection of salivary glands

Trial Locations (2)

28203

Carolinas MDA Neuromuscular/ALS Center; Carolinas Medical System; 1540 Garden Terrace, Charlotte

66160-7314

University of Kansas Medical Center/Neurology, 1008 Wescoe, Kansas City

All Listed Sponsors
collaborator

ALS Association

OTHER

collaborator

University of Kansas

OTHER

collaborator

Carolinas MDA Neuromuscular/ALS Center-Carolinas Medical System

UNKNOWN

lead

The University of Texas Health Science Center at San Antonio

OTHER

NCT00125203 - Study of Myobloc in the Treatment of Sialorrhea (Drooling) in Patients With Amyotrophic Lateral Sclerosis (ALS) | Biotech Hunter | Biotech Hunter